Proactive Investors - Run By Investors For Investors

Attis Industries stock soars after deal to collaborate with Novozymes

Novozymes has committed to supplying the enzymes required by Attis to convert its pulp into sugar at all its planned biorefineries
A generic representation of business collaboration
Attis focuses on building businesses that play important roles in the new economy like renewable fuels, bio-based plastics and healthcare

Attis Industries Inc (NASDAQ:ATIS) shares soared Friday after the diversified innovation and technology company said it will collaborate with Novozymes (NASDAQ OXM), a provider of advanced biological solutions.

Under the newly announced partnership, Novozymes has committed to supplying the enzymes required by Milton, Georgia-based Attis Industries to convert its pulp into sugar at its planned biorefineries.

Attis stock shot up 14.6% to $0.27 in morning trade.

READ: Arev Brands strikes C$1.2M deal to clinch Canna Gold's assets

Novozymes has a broad portfolio of biotechnology to support commercial cellulosic biofuels production, and the ability to ramp up production as needed in an effort to support Attis' ambitious growth plans.

Attis has successfully converted the pulp extracted from its patented biomass processing into high yields of sugar using Novozymes’ proprietary enzyme cocktails.  

These “positive results” have validated the planned business model at Attis' biorefineries, said the company.

Symbiotic partnership

"Attis is very excited about forming a partnership with Novozymes for the efficient production of ethanol at future biorefineries," said Attis Industries CEO Jeff Cosman. "Novozymes is the industry leader in biotechnology for the renewable fuel industry and brings with it unquestioned credibility to our renewable fuel goals."

The partnership will focus on improving value, yields, and process efficiencies. 

"Attis is very excited about forming a partnership with Novozymes for the efficient production of ethanol at future biorefineries," said Attis Industries CEO Jeff Cosman. "Novozymes is the industry leader in biotechnology for the renewable fuel industry and brings with it unquestioned credibility to our renewable fuel goals."

Attis Industries is a holding company focused on developing and building businesses that play important roles in the new economy, which include renewable fuels, bio-based plastics and healthcare.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

View full PROAC profile View Profile

Proactiveinvestors Timeline

Related Articles

clapperboard
December 19 2018
Interim profits showed a modest recovery with the number of contracts signed rising to 77 from 74 a year earlier
mobile marketing
February 01 2019
The merger is structured as an offer by Taptica that will see it owning 50.1% of the enlarged group and Rhythm One owning the remaining 49.9%
ipad
September 19 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use